BanafshehBShaibaniMD

Physician

Dr. Shaibani is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

NYU Grossman School of Medicine/Brooklyn CampusResidency, Family Medicine, 2001 - 2004
Shahid Beheshti University of Medical SciencesClass of 1998

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

PubMed

The new rHuEPO alpha (epotin) in the management of anemia of end-stage renal disease in patients on maintenance hemodialysis.
Abbas, E. E., Afioni, N., Al Wakeel, J., Bakr, M. A., Dham, R., Donia, A., Droubi, N., Khidir, E., Mathew, C. M., Mitwali, A. H., Naga, S., Pingle, A., Rashed, A., Ros...> ;Transplant Proc. 2004 Jul 01
Homocysteine and lipid peroxidation products: important atherosclerosis risk factors in renal allograft recipients?
Serafinowicz, A., Kuku?a, K., Cieciura, T., Shaibani, B., Baczkowska, T., Soin, J., Sadowska, A., Nowacka-Cieciura, E., Lewandowska, D., Rell, K., Durlik, M., Lao, M.> ;Transplant Proc. 2000 Sep
Effect of glucocorticoid-free immunosuppressive protocol on serum lipids in renal transplant patients.
Nowacka-Cieciura, E., Soluch, L., Cieciura, T., Lewandowska, D., Durlik, M., Shaibani, B., Serafinowicz, A., Szmidt, J., Rowi?ski, W., Lao, M.> ;Transplant Proc. 2000 Sep